T1	Outcomes 26 32	effect
T2	Outcomes 151 175	clinical curative effect
T3	Outcomes 366 380	nerve function
T4	Outcomes 599 631	treatment, nerve function defect
T5	Outcomes 731 756	Treatment effective rates
T6	Outcomes 852 919	reduce the GBS patients' blood immunoglobulin IgG, IgA, IgM, C3 and
T7	Outcomes 992 998	group.
T8	Outcomes 999 1006	Fib and
